Loading viewer...
report
Format: PDF report
This document is Ligand Pharmaceuticals' Q3 2017 quarterly report, detailing financial performance and compliance with SEC regulations.
presentation
report
CME Group
report
Dell Technologies
report
DTE Electric
report
EnscoRowan